Digital Health For Obesity Market Size, Share and Growth Outlook, 2026

Digital Health For Obesity Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Digital Health For Obesity Market size is forecast to increase from $78.42 Billion in 2026 to $397.66 Billion in 2034 at a CAGR of 22.5% between 2026 and 2034.

The Digital Health For Obesity market report provides detailed analysis and outlook of Digital Health For Obesity segments including By Application (Weight Management and Fitness Tracking, Behavioural Therapy, Virtual Clinical Consultations), By Therapeutic (Lifestyle & Behavioral Therapy, Pharmacotherapy-Integrated Digital Programs, Bariatric Surgery-Integrated Digital Programs, Metabolic Disease-Associated Obesity Programs, Prevention & Early Intervention Programs), By Technology Platform (Mobile Apps, Web-Based SaaS Platforms, Wearable-Integrated Solutions, Connected IoT Devices, AI) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Digital Health for Obesity Industry Overview

Integration of Digital Health Tools into Comprehensive Obesity Management

The digital health for obesity industry is evolving from simple weight-tracking applications toward comprehensive platforms that support long-term metabolic health, behavior modification, and chronic disease management. Healthcare organizations increasingly recognize that obesity treatment requires a combination of lifestyle interventions, continuous monitoring, and pharmacological support. Reflecting this trend, the American Heart Association issued a scientific statement emphasizing that physical activity should be considered a frontline intervention for obesity management regardless of weight loss outcomes. The organization highlighted the importance of integrating mobile health applications, wearable sensors, and digital monitoring technologies to encourage sustainable lifestyle changes and support patients receiving obesity medications, including GLP-1 receptor agonists. This approach is strengthening the role of digital health platforms as essential tools for personalized obesity care and long-term health improvement.

Artificial Intelligence and Data Analytics Driving Preventive Strategies

Artificial intelligence, bioinformatics, and population-level data analysis are becoming increasingly important in obesity prevention and risk identification programs. Public health organizations and research institutions are leveraging large-scale datasets to better understand the biological and environmental factors contributing to obesity development. The European Health and Digital Executive Agency has highlighted initiatives such as BETTER4U, which utilizes AI-powered intervention methodologies for obesity prevention. These projects combine bioinformatics capabilities with extensive biobank resources to identify early-life markers associated with obesity risk and develop evidence-based prevention frameworks. By applying advanced analytics to large health datasets, digital health solutions are supporting more proactive public health strategies, personalized interventions, and data-driven obesity prevention programs aimed at reducing long-term disease burden.

Regulatory Changes Reshaping Digital Obesity Care Models

Regulatory developments continue to influence the operational strategies of digital obesity management providers. The growing adoption of GLP-1 therapies has created new opportunities for digital-first obesity clinics that combine medication management with virtual care, coaching, and remote monitoring services. However, regulatory authorities are increasing oversight of treatment delivery models. The FDA announced a formal enforcement initiative targeting non-FDA-approved compounding of GLP-1 receptor agonists, affecting digital health providers that previously relied on compounded formulations during periods of supply constraints. This regulatory action is encouraging obesity management platforms to strengthen compliance frameworks and establish partnerships that ensure access to approved therapies. As digital obesity care continues to mature, providers are increasingly focusing on integrated care models that combine evidence-based behavioral interventions, wearable technologies, and regulated pharmacological treatments.

Digital Health For Obesity Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Digital Health For Obesity market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Novo Nordisk , Eli Lilly and Company , Noom, Inc., ResMed , Teladoc Health , WW International, Inc. , BetterUp , Found , Omada Health, Amgen. The Digital Health For Obesity market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Digital Health For Obesity industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Digital Health For Obesity Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Digital Health For Obesity companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Digital Health For Obesity markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Digital Health For Obesity Market Competitive Benchmarking and Company Analysis

Leading companies in Digital Health For Obesity industry include- Novo Nordisk , Eli Lilly and Company , Noom, Inc., ResMed , Teladoc Health , WW International, Inc. , BetterUp , Found , Omada Health, Amgen. The Digital Health For Obesity market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Digital Health For Obesity Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Digital Health For Obesity market remains one of the strongest-performing segments in the country.
The US Digital Health For Obesity Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Digital Health For Obesity market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Digital Health For Obesity industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Digital Health For Obesity markets

Canada's strong Digital Health For Obesity sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Digital Health For Obesity market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Digital Health For Obesity Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Digital Health For Obesity market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Digital Health For Obesity population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Digital Health For Obesity industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Digital Health For Obesity market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Digital Health For Obesity sales through 2034

France Digital Health For Obesity companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Digital Health For Obesity Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Digital Health For Obesity distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Digital Health For Obesity Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Digital Health For Obesity market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Digital Health For Obesity industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Digital Health For Obesity industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Digital Health For Obesity Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Digital Health For Obesity market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Digital Health For Obesity market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Digital Health For Obesity Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Digital Health For Obesity Market Segmentation

By Application
Weight Management and Fitness Tracking
Behavioural Therapy
Virtual Clinical Consultations
By Therapeutic
Lifestyle & Behavioral Therapy
Pharmacotherapy-Integrated Digital Programs
Bariatric Surgery-Integrated Digital Programs
Metabolic Disease-Associated Obesity Programs
Prevention & Early Intervention Programs
By Technology Platform
Mobile Apps
Web-Based SaaS Platforms
Wearable-Integrated Solutions
Connected IoT Devices
AI

Top Companies in Digital Health For Obesity Industry

Novo Nordisk
Eli Lilly and Company
Noom, Inc.
ResMed
Teladoc Health
WW International, Inc.
BetterUp
Found
Omada Health
Amgen

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025